Inverna Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 45161641
Cortex Park 26 E, 5230 Odense M
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| External services | - 158.90 |
| Gross profit | - 158.90 |
| EBIT | - 158.90 |
| Pre-tax profit | - 158.90 |
| Net earnings | - 158.90 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current other receivables | 77.29 |
| Short term receivables total | 77.29 |
| Cash and bank deposits | 3 724.48 |
| Cash and cash equivalents | 3 724.48 |
| Balance sheet total (assets) | 3 801.76 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 55.99 |
| Share premium account | 3 708.75 |
| Profit of the financial year | - 158.90 |
| Shareholders equity total | 3 605.84 |
| Non-current liabilities total | |
| Current trade creditors | 195.92 |
| Current liabilities total | 195.92 |
| Balance sheet total (liabilities) | 3 801.76 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.